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httpcense.Abstract Background: In patients with Obstructive sleep apnea (OSA), the risks of fatal and non-
fatal cardiovascular diseases and coronary artery disease are increased and measuring carotid
intima-media thickness (CIMT) can assess these complications.
Aim: Studying the effect of OSA syndrome in the carotid artery wall thickness as an indicator to
cardiovascular complications, and the effect of CPAP on these changes.
Subjects and methods: Polysomnography (PSG) was done for 45 patients; 29 patients of them
proved to have OSA, and 10 obese subjects with normal PSG were included as a control group.
All of them had ultrasonographic assessment of CIMT. 17 patients with OSA used CPAP overnight
for 6 months and the CIMT was remeasured.
Results: 29 were diagnosed with OSA (12 severe, 9 moderate and 8 mild OSA). There was a
highly signiﬁcant difference (p< 0.01) in CIMT between patient and control groups, and also
between severe and mild OSA patients with non-signiﬁcant difference (p> 0.05) between severe
and moderate OSA. Regarding the different risk factors predispose to atherosclerosis, only factors
related to OSA syndrome were correlated with CIMT. There was a highly signiﬁcant reduction
(p< 0.01) in CIMT after six months of CPAP usage.
Conclusions: CIMT as a marker of atherosclerosis is signiﬁcantly increased in patients with OSA
and the use of CPAP in those patients is very important not only for improving sleep efﬁciency but
also for reducing cardiovascular complications associated with OSAS.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.1004774422.
oo.com (M.A. Agha).
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Obstructive sleep apnea is characterized by recurrent collapse
of the pharyngeal airway during sleep, resulting in reduction
(hypopnea) or complete cessation (apnea) of airﬂow despite
the ongoing breathing efforts. These disruptions to breathing
lead to intermittent hypercapnia and hypoxemia and surges
of sympathetic activation. Loud snoring is a typical featureis. Production and hosting by Elsevier B.V.
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156 M.A. Agha, R.M. Habibof OSA and in most cases the culmination of a respiratory
event is associated with a brief awakening from sleep (arousal).
These events result in fragmented sleep as the patient oscillates
between wakefulness and sleep. In severe cases respiratory
events can occur more than 100 times per hour and typically
each event last 20–40 s [1,2]. These events may include any
combination of obstructive apnea, hypopnea, or respiratory ef-
fort–related arousals [3]. The stress caused by recurrent epi-
sodes of apnea results in increased levels of endogenous
endothelin-1 a long-lasting vasoconstrictor. Blood pressure
and endothelin-1 concentrations were increased after 4 h of un-
treated obstructive apneas, and decreased after 5 h of continu-
ous positive airway pressure (CPAP) treatment [4]. In contrast,
nitric oxide, which is a known vasodilator, has been reported
to be reduced in patients with obstructive sleep apnea syn-
drome (OSAS). The increased endothelin and reduced nitric
oxide levels have been reported to reverse with the use of
CPAP [5]. Moreover, It has been suggested that endothe-
lium-dependent vascular dysfunction in patients with OSAS
plays a role in the development of atherosclerosis. Vascular
endothelial growth factor (VEGF), a hypoxia-sensitive glyco-
protein that stimulates neoangiogenesis is associated with vas-
cular remodeling and its levels are closely correlated with the
degree of nocturnal oxygen desaturation [6]. Vascular remod-
eling may cause an increase in the arterial blood pressure. It
has been reported that amelioration of nocturnal hypoxia by
CPAP is associated with a decrease in the serum levels of
VEGF [7]. In patients with OSAS, the risk of fatal and non-
fatal cardiovascular diseases and coronary artery disease is in-
creased. A parallel increase in the severity of OSAS and the
cardiovascular events has also been described. OSAS is often
associated with cardiovascular risk factors, such as diabetes
mellitus, hyperlipidemia and obesity [8]. Untreated OSAS is
also associated with dysglycemia, systemic inﬂammation,
endothelial dysfunction, platelet activation, and other cardio-
vascular consequences such as cardiac arrhythmias especially
atrial ﬁbrillation (AF), coronary artery disease, asymptomatic
early atherosclerosis, and silent brain infarction [9]. Moreover,
the hypoxia, negative intrathoracic pressure, and arousal in-
duced by upper-airway obstruction during sleep, as well as re-
peated activation of the sympathetic nervous system, have
various effects on blood pressure and coagulation factors that
may lead to an increased risk of cardiovascular morbidity [10].
CIMT is a useful marker for investigating the degree of early
atherosclerosis. Several clinical studies have demonstrated that
an increase in ultrasonographically measured CIMT is associ-
ated with elevated risks of cardiovascular diseases and stroke
[11]. CIMT, as evaluated by ultrasound, correlates well with
anatomic measurements and is recognized as a marker of pre-
clinic atheroma. An increased CIMT is accepted as a potent
predictor of myocardial infarction and stroke, even after
adjustment for other risk factors. Accordingly, ultrasonogra-
phy measurement intima-media thickness (IMT) has recently
become established as a method of assessing the early stage
of atherosclerosis. It also has been reported that the carotid-ar-
tery IMT is increased in patients with hypertension, hyperlip-
idemia, or diabetes mellitus, as well as in the elderly [12].
Different studies have investigated the effect of OSA on ath-
erosclerosis, and it has been demonstrated that the levels of
soluble adhesion molecules, VEGF, and coagulation factors
are increased in OSA patients, compared with control subjects,
and are signiﬁcantly decreased by the use of CPAP therapy.These studies have suggested that OSA may be associated with
the progression of atherosclerosis [13–15].
Aim of the work
The aim of this work was to assess the effect of OSAS in the
carotid artery wall thickness as an indicator to cardiovascular
complications, and to study the effect of CPAP usage on these
changes.
Subjects and methods
Patients with symptoms and signs of sleep breathing disor-
ders recruited from the chest department, Menouﬁya Univer-
sity Hospitals were initially included. Those patients were
subjected to: complete history taking, clinical examination
both general and chest examinations. Patients were referred
to the sleep disorders unit in Menouﬁya University Hospital
where a sleep questionnaire was completed including the pa-
tient’s symptoms, anthropometric measures (height, weight
and neck circumference), his sleep habits, and the Epworth
sleepiness scale (ESS) [16]. Then, overnight polysomnography
(PSG) was performed for patients using Embla S4000 Med-
care, Iceland. The system has the following components:
Somnologica studio 3.3.2 software; Pulse oximetery sensor,
Airﬂow nasal pressure cannula; Airﬂow thermistor; Respira-
tory inductive plethysmography belts with thoracic and
abdominal locks; Snoring microphone; Body position sensor;
EEG electrodes with their cables; EOG electrodes; EMG elec-
trodes for the chin and anterior tibialis muscle; and ECG
electrodes with their cables. Patients were studied at night
for at least 6 h. All studies were analyzed by sleep physicians
using the criteria of Rechtschaffen and Kales [17] and in close
concordance with scoring updates given by the American
Academy of Sleep Medicine [18]. Apneas were scored when
there was a complete cessation of airﬂow or P90% drop in
the peak thermal sensor excursion for at least 10 s. Hypopne-
as were scored when there was a drop in the nasal pressure
by P30% of baseline lasting at least 10 s with a P4% desat-
uration from pre-event baseline, or when there was a drop in
the nasal pressure signal excursion by P50% of baseline last-
ing at least 10 s with a P3% desaturation from pre-event
baseline. The apnea–hypopnea index (AHI) which is number
of apnea–hypopnea events per hour was determined after the
exclusion of periods with movements, which were considered
to be wake periods.
In the next morning, a fasting venous blood sample
was taken for Fasting and 2 h post prandial blood
glucose, lipid proﬁle [included; high density lipoprotein
(HDL), low density lipoprotein (LDL), triglycerides and
Cholesterol].
The 29 patients diagnosed to have OSA and 10 subjects
with normal polysomnographic ﬁndings but with BMI >30
(control group) were referred for measuring carotid IMT using
ultraonography.
Carotid IMT assessment: [19] Carotid artery IMT was as-
sessed by B-mode ultrasound scanning with a 10-MHz linear
phase array transducer (Hitachi AUB 7000). The patient’s
head was rotated away from the side being examined. The
evaluation of common carotid arteries was done in a longitu-
dinal plane then conﬁrmed in axial plans. Bilateral IMT (the
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of the media/adventitia echo) measurements were obtained at
the distal 10 mm of the common carotid artery. Three mea-
sures were taken for each side and the mean measure was cal-
culated. The carotid scan operator was blinded to the clinical
treatment status of the studied subjects and was not involved
in the clinical assessment.
 Normal measures of carotid intima-media: 0.04–0.07 cm
with 0.001 cm more in female.
 Equivocal measures: 0.07–0.11 cm.
 Atherosclerotic measures >0.11 cm.
Patients with conﬁrmed OSA were re-refered to the sleep
disorders unit in the Menouﬁya University Hospital for a titra-
tion study using the same system in addition to CPAP device
(Fisher & Paykel Sleep Style 254) to document abolishing of
respiratory events and to determine the appropriate pressure
needed for each patient. Patients were encouraged to use
CPAP every night for six consecutive months. A follow up
CIMT study was done and the same measurements were taken
and compared to the initial ones.
Statistical methodology [20]
The data collected were tabulated & analyzed by SPSS (statis-
tical package for the social science software) statistical package
version 11 on IBM compatible computer. Quantitative data
were expressed as mean and standard deviation (X ± SD).
ANOVA test for analysis of variance (f-test) was used for com-
parison of more than two groups of normally distributed vari-
ables; and krauskal wallis test was used for comparison of
more than two groups of non-normally distributed variables.
Students T test was used for comparison of two quantitative
variables. Qualitative data were expressed as number and per-
centage (No and %) and analyzed by applying chi-square test
(X2). Pearson correlation (r) was used to detect association be-Table 1 Comparisons between patients and control groups regardi
Variable Control obese OSA
Age 52.80±8.403 53.3
Sex
Male 4 40% 18 6
Female 6 60% 11 3
HTN
Present 4 40% 10 3
Absent 5 60% 19 6
DM
Present 5 50% 10 3
Absent 5 50% 19 6
Dyslipidemia
Present 7 70% 6 37
Absent 3 30% 18 6
BMI 40.34± 5.71 37.9
Smoking
Yes 2 20% 7 41
No 8 80% 17 5
*: t test. OSA: obstructive sleep apnea. BMI: body mass index. HTN: hytween quantitative variables. All these tests were used as:  P
value >0.05 was considered statistically non-signiﬁcant.  P
value 60.05 was considered statistically signiﬁcant.  P value
60.01 was considered statistically highly signiﬁcant.
Results
From the 45 patients who were initially included and did the
polysomnographic study, 29 patients had OSA syndrome,
and of the remaining 16 cases (14 normal, and 2 mixed sleep
apnea), 10 subjects with normal polysomnographic ﬁndings
with BMI >30 were included as a control obese group. The
proved 29 cases with OSA were; 12 cases with severe OSA, 9
cases with moderate OSA, and 8 cases with mild OSA. All
the 29 patients and the 10 control cases had initially measured
carotid IMT using ultrasonography. In the present study there
were no signiﬁcant differences between patients and the con-
trol groups in general characteristics such as sex, age, BMI
and risk factors for atherosclerosis (Table 1). Regarding ply-
somnographic data, there were signiﬁcant differences between
OSA patients and the control group and also regarding the
severity of OSA. (Table 2) Table 3 and Table 4 show that there
was a marked increase in CIMT in patients with OSA com-
pared to the control group and this increase was a highly sig-
niﬁcant difference between patients with severe or moderate
OSA and the control group and also this increase was signiﬁ-
cantly different in regard to patients with mild OSA. Also,
there was a highly signiﬁcant increase in CIMT between mild
and severe OSA patients with no difference between patients
with moderate and severe OSA. From different factors that
are already known to predispose to atherosclerosis (such as,
DM, HTN, BMI, smoking, age and dyslipidemia) only factors
related to the OSA syndrome were found to be signiﬁcantly
correlated with the degree of CIMT (O2 desaturation, Lowest
O2 Saturation, SaO2 < 90% of TST, and AHI). (Table 5) Pa-
tients with moderate and severe OSA were recommended to
use overnight CPAP. From the 21 cases with moderate orng different characteristics.










3± 8.65 *0.815 >0.05
.4%
8.6% 1.47 >0.05
pertension. DM: diabetes mellitus.
Table 2 Polysomnographic characteristics in the studied groups.
Variable Control obese OSA (total) Mild OSA Moderate OSA Severe OSA ANOVA P-Value
AHI 2.72 ± 1.99 24.54 ± 22.45 9.31 ± 2.63 24.4 ± 5.3 53.01 ± 15.10 67.59 <0.001*
TST 393.5 ± 47.35 313.21 ± 77.19 358.78 ± 39.68 284.30 ± 46.71 237.58 ± 43.09 26.56 <0.001*
Sleep eﬀ 77.67 ± 7.15 68.75 ± 8.93 72.21 ± 6.16 64.42 ± 5.06 62.26 ± 6.97 12.43 <0.001*
SaO2 <90% 1.02 ± 1.82 15.41 ± 12.70 6.60 ± 4.41 23.62 ± 6.96 27.14±7.54 48.94 <0.001*
Lowest O2 90.75 ± 2.20 75.85 ± 14.32 84.25 ± 3.84 75.44 ± 7.76 58.16 ± 7.58 60.39 <0.001*
Average O2 96..12 ± 1.39 91.11 ± 5.61 93.9 ± 1.57 91.66 ± 2.56 84.66 ± 5.15 25.09 <0.001*
ESS 3.40 ± 1.64 9.92 ± 4.24 10.25±1.28 12.66 ± 1.00 13.08 ± 1.56 101.45 <0.001*
OD 4.92 ± 4.17 27.27 ± 27.21 9.11 ± 3.67 30.31 ± 15.97 55.73 ± 27.65 19.01 <0.001*
OSA: obstructive sleep apnea. AHI: apnea-hypopnea index. TST: total sleep time. ESS: the Epworth sleepiness scale. OD: oxygen desaturation.
Eff: efﬁciency. *: highly signiﬁcance difference.
Table 3 Intima-media wall thickness in the studied groups before use of the CPAP.
Variable Control obese OSA (total) Mild OSA Moderate OSA Severe OSA ANOVAtest p-Value
IMT 0.084 ± 0.23 0.131 ± 0.04 0.11 ± 0.02 0.15 ± 0.017 0.166 ± 0.032 24.63 <0.01*
OSA: obstructive sleep apnea. IMT: intima-media thickness. *: highly signiﬁcance difference.
Table 4 Comparison between different groups regarding IMT before the use of the CPAP.
Groups IMT X ±SD t-test P-Value
Control 0.084 ± 0.23 6.808 < 0.001*
Severe OSA 0.166 ± 0.032
Control 0.084 ± 0.23 7.16 < 0.001*
Moderate OSA 0.15 ± 0.017
Control 0.084 ± 0.23 2.45 < 0.05 s
Mild OSA 0.11 ± 0.02
Mild OSA 0.11 ± 0.02 4.503 < 0.001*
Severe OSA 0.166 ± 0.032
Mild OSA 0.11 ± 0.02 4.701 < 0.001*
Moderate OSA 0.15 ± 0.017
Moderate OSA 0.15 ± 0.017 1.214 > 0.05
Severe OSA 0.166 ± 0.032
Control 0.084 ± 0.23 5.32 < 0.001*
Total OSA 0.131 ± 0.04
OSA: obstructive sleep apnea. IMT: intima-media thickness SD: standared deviation. *: highly signiﬁcance difference. S: signiﬁcance difference.
Table 5 Pearson correlation coefﬁcient between IMT and diff
risk factors in OSA patients.








Lowest O2 Saturation 0.795 <0.001
SaO2 < 90% of TST 0.736 <0.001
OD 0.684 <0.001
OSA: obstructive sleep apnea. BMI: body mass index. HTN:
hypertension. DM: diabetes mellitus.
BMI: body mass index. AHI: apnea-hypopnea index. OD: oxygen
desaturation.
158 M.A. Agha, R.M. Habibsevere OSA, 17 cases use the overnight CPAP regularly for
6 months while the remaining 4 cases did not. After the
6 months of regular use of the overnight CPAP, the 17 patients
did another measurement of CIMT where there was a marked
signiﬁcant reduction in the IMT patients with severe and mod-
erate OSA (Table 6).
Discussion
Obstructive sleep apnea syndrome is characterized by repetitive
episodes of upper airway obstruction causing daytime sleepi-
ness, impaired cognitive function and poor health status [21].
In patients with obstructive sleep apnea syndrome, the risk of
fatal and non-fatal cardiovascular diseases and coronary artery
disease is increased [8]. CIMT has recently become established
as a method of assessing the early stage of atherosclerosis [12].
So, the aim of the present study was to evaluate the cardiovas-
Assessment of Carotid Artery Wall In Patients With OSA Syndrome 159cular complication in patients with obstructive sleep apneas by
measuring CIMT and study the effect of using the overnight
CPAP on CIMT. In this work, 10 control obese patients not
complaining from OSAS were included and there was no signif-
icant difference (p value <0.01) between them and the OSA pa-
tients group regarding the general characteristics (age, sex,
BMI, DM, dyslipidemia, and smoking habits) and this matched
characteristics helped us in studying the effect of OSA as a pre-
disposing factor for atherosclerosis. The previous ﬁndings were
in accordance with that of Silvestrini [22] who did not exclude
risk factors from the studied group but used matched groups,
while Minoguchi [23] excluded patients with hypertension, dia-
betes, or hyperlipidemia because these conditions can increase
carotid IMT while age and body mass index, which also affect
carotid IMT, were matched between patients with OSA and ob-
ese control subjects. In the present study there was a marked in-
crease in CIMT in patients with OSA compared to the control
group and this increase was a highly signiﬁcant difference (p va-
lue <0.01) between patients with severe or moderate OSA and
the control group and also this increase was signiﬁcantly differ-
ent (p value <0.05) regarding patients with mild OSA. Also,
there was a highly signiﬁcant increase in CIMT frommild to se-
vere (p value <0.01). The previous ﬁndings are in agreement
with that of Schulz [24] who found that Carotid IMT was sig-
niﬁcantly elevated in patients with OSA compared with obese
control subjects (1.07 ± 0.05 vs. 0.71 ± 0.03 mm, p< 0.001).
In addition, carotid IMT in patients with moderate to severe
OSA (1.16 ± 0.05 mm) was signiﬁcantly elevated compared
with patients with mild OSA (0.92 ± 0.07 mm, p< 0.003) or
compared with obese control subjects (0.71 ± 0.03 mm,
p< 0.0001). Also, the present work’s results conﬁrmed with
that of Schulz [24] where ultrasonography of the large extracra-
nial vessels was performed in a group of consecutively admitted
OSA patients (n= 535) and a control group of non-OSA pa-
tients (n= 535) and CIMT was measured at the far wall of
both proximal carotid arteries. They [24] found that mean
CCA-IMT was markedly increased in the OSA patients when
compared with the control group (p< 0.01). Suzuki [25] agreed
with the previous results and concluded that OSA is indepen-
dently related to atherosclerosis, and that the severity of
OSA-related hypoxemia is more important than is the fre-
quency of obstructive events. Jean-Philippe Baguet [26] stated
the same conclusion. In this study by using Pearson correlation
for different factors that are already known to predispose to
atherosclerosis (such as, DM, HTN, BMI, smoking, age and
dyslipidemia), only factors related to the OSA syndrome were
found to be signiﬁcantly correlated with the degree of CIMT
(O2 desaturation, Lowest O2 Saturation, SaO2 < 90% of
TST, and AHI). The previous ﬁndings are in agreement with
many studies [24–26] in that the severity of oxygen desaturation
and the longer period of SaO2 < 90% of TST, the more severe
degree of CIMT and so the more incidence of atherosclerosis.Table 6 IMT before and after the use of CPAP.
Variable IMT before IMT aft
Moderate 0.15 ± 0.017 0.097 ±
Severe 0.166 ± 0.032 0.10 ±
Total 0.131 ± 0.04 0.99 ±
OSA: obstructive sleep apnea. IMT: intima-media thickness. *: highly sigSuzukki [25] found That IMT was signiﬁcantly correlated with
the AHI (r= 0.327; P< .001), T90 (r= 0.354; P< .001), and
the mean nadir oxygen saturation (r= 0.331; P< .001) by
Pearson’s correlation analysis. But unlike the present study,
by the same analysis they also found that IMT was also signif-
icantly correlated with age (r= 0.469; P< .001), BMI
(r= 0.188; P< .05), total cholesterol (r= 0.187; P< .05),
HbA1c (r= 0.264; P< .001), and systolic blood pressure
(r= 0.174; P< .05). This difference may be a result of a small
number of patients (29 cases of OSA) compared to 167 patients
in Suzuki’s study [25], also in Suzuki’s study [25] there was no
control group like the present study. Also Minoguchi [23] con-
cluded that the primary factor inﬂuencing carotid IMT was the
duration of hypoxia during total sleep time (p< 0.036) and
these results suggested that OSA related hypoxia and systemic
inﬂammation might be associated with the progression of ath-
erosclerosis and thus might increase the risks of cardiovascular
and cerebrovascular morbidity in patients with OSA. Minogu-
chi [23] found that carotid IMT was positively correlated with
age (r= 0.41, p< 0.004), AHI (r= 0.50, p< 0.002), and per-
centage of time with SaO2 was less than 90% (r= 0.60,
p< 0.0001), this difference between this study and Minogu-
chi’s study [23] in the positive correlation of age [23] may be
due to the difference in the range of ages they studied 23y to
65 y while the range in the present study was 38–72 and also
in the number of the studied group in this work was 29 patients
and 10 controls while in this work while 36 patients and 16 con-
trol in their work. In this work the effect of CPAP on CIMT
was studied. Patients with moderate and severe OSA were rec-
ommended to use overnight CPAP. From the 21 cases with
moderate or severe OSA, 17 cases use the overnight CPAP
regularly for 6 months while the remaining 4 cases did not.
After the 6 months of regular use of the overnight CPAP, the
17 patients did another measuring of CIMT where there was
a marked signiﬁcant reduction (p< 0.001) in the IMT patients
with either severe or moderate OSA. The importance of CPAP
usage in patients with OSA in the reduction of CIMT was con-
ﬁrmed by Hui [27] who found that in a group of 50
symptomatic patients newly diagnosed with severe OSAS,
showed that CPAP treatment (n= 28) resulted in a signiﬁcant
reduction in the carotid artery IMT compared to those who had
opted for conservative treatment (CT, n= 22) over a study
period of 12 months. Most of the reductions in the carotid
artery IMT when comparing CPAP against the CT group ap-
peared to have occurred within the ﬁrst 6 months of
treatment whereas there was no signiﬁcant change from 6 to
12 months while the patients had maintained reasonable
CPAP usage objectively throughout the study. The previous
ﬁndings were also conﬁrmed by the Baguet study [26] who
conﬁrmed the CPAP enables the reduction of cholesterol
levels, systemic inﬂammation and improves nitric oxide
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Obstructive sleep apnea syndrome is associated with cardiovas-
cular complications which can be assessed by measuring the
carotid intima-media thickness. CIMT is signiﬁcantly increased
in patients with OSAS and the use of CPAP in those patients is
very important not only for improving sleep efﬁciency but also
for reducing cardiovascular complications associated with
OSAS. But more studies should be done for assessment of the
effect of OSA patients free of any risk factors on CIMT, also,
studies on the effect of CPAP serially within longer and shorter
periods to select the optimum period for its use and the effect of
CPAP usage on different associated risk factors and inﬂamma-
tory markers associated with the OSAS.
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